Notes from the Field: Severe Health Outcomes Linked to Consumption of Mushroom-Based Psychoactive Microdosing Products - Arizona, June-October 2024.
Heather L. Walker, Maureen Roland, Steven Dudley, Kenneth Komatsu, Joli Weiss, Jamaica Dillard, Hsin-I Lin, Laura Rust, Traci Plummer, Rachel Berg, Stephen Everett, Arthur Chang, Michael Yeh, Johnni Daniel, Shane Brady
MMWR Morb Mortal Wkly Rep January 9, 2025 DOI: 10.15585/mmwr.mm7401a3 via PubMed Central
Summary
AI-generated from the abstractBetween June and October 2024 in Arizona, severe health outcomes were linked to the consumption of mushroom-based psychoactive microdosing products. The report describes cases of illness associated with these products, highlighting the potential dangers of unregulated psychoactive substances marketed for microdosing.
Study at a glance
| Characteristics | Case series Case report Peer reviewed |
|---|---|
| Sample size | 9 |
| Population | Individuals in Arizona who consumed mushroom-based psychoactive microdosing products and experienced severe health outcomes |
| Citations | 1 |
| Key finding | Consumption of mushroom-based psychoactive microdosing products in Arizona from June to October 2024 was associated with severe health outcomes. |
Abstract
Notes from the Field: Severe Health Outcomes Linked to Consumption of Mushroom-Based Psychoactive Microdosing Products - Arizona, June-October 2024.